SBH
AGN

Segall Bryant & Hamill’s Allergan Inc AGN Stock Holding History

Segall Bryant & Hamill’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-31,926
Closed -$6.79M – 581
2014
Q4 		$6.79M Sell
31,926
-2,270
-7% -$451K 0.15% 183
2014
Q3 		$6.09M Sell
34,196
-19,973
-37% -$3.32M 0.14% 187
2014
Q2 		$9.17M Sell
54,169
-155,171
-74% -$24.2M 0.22% 154
2014
Q1 		$26M Sell
209,340
-1,926
-0.9% -$235K 0.62% 42
2013
Q4 		$23.5M Sell
211,266
-2,335
-1% -$223K 0.55% 59
2013
Q3 		$19.3M Buy
213,601
+38,393
+22% +$3.45M 0.48% 67
2013
Q2 		$14.8M Buy
+175,208
New +$18.2M 0.39% 87

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Segall Bryant & Hamill's AGN Position: Q1 2015 in Review

Segall Bryant & Hamill sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 31,926 shares — an estimated $6.79M sold.

Segall Bryant & Hamill first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $26M in Q1 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Segall Bryant & Hamill reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Segall Bryant & Hamill sold 31,926 Allergan Inc shares in Q1 2015, an estimated $6.79M.
  • Segall Bryant & Hamill first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Segall Bryant & Hamill's Allergan Inc position peaked at $26M in Q1 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Segall Bryant & Hamill's 13F filing for Q1 2015, filed 14 May 2015.